Jeff Yass’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-16,800
Closed -$305K 14300
2021
Q3
$305K Buy
16,800
+2,700
+19% +$61.9K ﹤0.01% 10575
2021
Q2
$381K Sell
14,100
-16,800
-54% -$470K ﹤0.01% 10254
2021
Q1
$926K Sell
30,900
-39,100
-56% -$1.33M ﹤0.01% 7950
2020
Q4
$2.01M Sell
70,000
-38,500
-35% -$1.04M ﹤0.01% 5080
2020
Q3
$2.65M Buy
108,500
+23,400
+27% +$505K ﹤0.01% 4090
2020
Q2
$1.52M Buy
85,100
+31,200
+58% +$410K ﹤0.01% 5009
2020
Q1
$439K Sell
53,900
-10,100
-16% -$115K ﹤0.01% 7206
2019
Q4
$845K Sell
64,000
-49,400
-44% -$598K ﹤0.01% 5861
2019
Q3
$1.35M Buy
113,400
+104,300
+1,146% +$1.93M ﹤0.01% 5053
2019
Q2
$223K Buy
+9,100
New +$262K ﹤0.01% 8917

Other funds holding CVET

Jeff Yass's CVET Position: Q4 2022 in Review

Jeff Yass sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 30,363 shares — an estimated $634K sold.

Jeff Yass first reported a position in CVET in Q1 2019 and held it in 12 quarters. The position peaked at $4.91M in Q2 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Jeff Yass reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 30,363 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $634K.
  • Jeff Yass first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 12 quarters.
  • Jeff Yass's Covetrus, Inc. Common Stock position peaked at $4.91M in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.